OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
Publish Date Publish Date | Title Title | Period End Date Period End Date | Status Status |
---|---|---|---|
08/13/2023 | Quarterly Report - Quarterly Report 06/30/2023 | 06/30/2023 | A |
06/19/2023 | Attorney Letter with Respect to Current Information - All periods from 12/31/2021 through 03/31/2023 | 03/31/2023 | A |
06/19/2023 | Supplemental Information - Change of Control | 03/31/2023 | A |
06/15/2023 | Quarterly Report - Quarterly Report 03/31/2023 (Amended) | 03/31/2023 | A |
06/15/2023 | Annual Report - 2022 Annual Report (Amended) | 12/31/2022 | A |
06/15/2023 | Annual Report - 2021 Annual Report (Amended) | 12/31/2021 | A |
06/08/2023 | Quarterly Report - Quarterly Report 03/31/2023 | 03/31/2023 | A |
06/08/2023 | Annual Report - Annual Report 2022 | 12/31/2022 | A |
06/08/2023 | Annual Report - Annual Report 2021 | 12/31/2021 | A |
07/22/2015 | OTCQB Certification | 12/31/2014 | A |
Form Type Form Type | Received Received | Period End Date Period End Date | Report Report |
---|---|---|---|
SC 13G | 01/11/2022 | ||
15-12G | 05/23/2018 | ||
10-Q | 02/05/2018 | 09/30/2017 | |
10-Q | 02/05/2018 | 06/30/2017 | |
8-K | 01/10/2018 | 10/30/2017 | |
8-K | 11/07/2017 | 11/03/2017 | |
8-K | 11/01/2017 | 10/26/2017 | |
NT 10-Q | 08/15/2017 | 06/30/2017 | |
10-K/A | 07/28/2017 | 12/31/2016 | |
10-Q | 06/01/2017 | 03/31/2017 |
No insider disclosure available for FBEC.
No SEC transactions available for FBEC.